In a patient with severe acute respiratory distress syndrome on day 10 who has been kept supine, should I initiate an airway pressure release ventilation (APRV) trial with spontaneous breathing?

APRV Should Not Be Routinely Used in Day 10 Severe ARDS

Based on current evidence-based guidelines, you should NOT initiate APRV at this stage; instead, continue with established lung-protective ventilation strategies that have proven mortality benefit. The most recent ATS guidelines 1, 2 do not recommend APRV as a standard ventilation mode for ARDS, and the highest quality randomized trial shows no benefit over conventional low tidal volume ventilation 3.

Why APRV Is Not Recommended

Guideline-Based Approach

The 2024 ATS Clinical Practice Guideline 1 and 2017 ATS/ESICM/SCCM guideline 2 establish clear ventilation priorities for severe ARDS:

Strong recommendations (what you SHOULD be doing):

• Low tidal volume ventilation (4-8 mL/kg PBW) with plateau pressure <30 cmH₂O 1, 2
• Prone positioning >12 hours/day for severe ARDS 2
• Higher PEEP strategies (conditional recommendation) 1
• Neuromuscular blockade in early severe ARDS (conditional) 1

APRV is conspicuously absent from these evidence-based recommendations.

The Evidence Against APRV

The most recent and highest quality study directly addressing your question is a 2022 randomized controlled trial 3 comparing APRV versus low tidal volume ventilation in 90 patients with severe COVID-19 ARDS:

Key findings:

• No difference in ventilator-free days (primary outcome)
• No mortality benefit (78% APRV vs 60% low tidal volume, p=0.07)
• Higher risk of severe hypercapnia (42% vs 15%, p=0.009)
• Higher tidal volumes and mean airway pressures with APRV
• No improvement in clinically meaningful outcomes

This contradicts the theoretical benefits suggested by older, lower-quality observational studies 4, 5.

What You Should Do Instead

Day 10 Severe ARDS Management Algorithm:

1. Verify lung-protective ventilation parameters:

   • Tidal volume 4-6 mL/kg PBW (lower end for severe ARDS)
   • Plateau pressure ≤30 cmH₂O
   • Driving pressure as low as achievable (ideally <15 cmH₂O)

2. Ensure prone positioning implementation:

   • If not already doing so, initiate prone positioning >12 hours daily 2
   • This has the strongest evidence for mortality reduction in severe ARDS

3. Optimize PEEP strategy:

   • Use higher PEEP approach (typically 12-15 cmH₂O or higher) 1
   • Titrate based on oxygenation and compliance
   • Avoid prolonged recruitment maneuvers (strong recommendation against) 1

4. Consider adjunctive therapies:

   • Corticosteroids if not already initiated 1
   • Neuromuscular blockade if in early severe phase 1
   • VV-ECMO consultation if refractory hypoxemia despite optimized ventilation 1

Critical Pitfalls to Avoid

Do not use APRV as a "rescue" mode simply because conventional strategies seem inadequate. The 2022 RCT 3 specifically tested this scenario and found no benefit. Instead:

• Reassess whether all evidence-based interventions are optimized
• Consider whether the patient meets criteria for ECMO referral
• Evaluate for complications (pneumothorax, auto-PEEP, cardiac dysfunction)

The spontaneous breathing component of APRV is not inherently beneficial. While older studies 5, 6 suggested physiological advantages, these did not translate to improved outcomes in the definitive RCT 3. Spontaneous breathing can be safely incorporated within conventional pressure support or SIMV modes once appropriate.

When Spontaneous Breathing IS Appropriate

At day 10, if the patient is improving and you're considering transitioning from controlled to assisted ventilation:

• Use conventional pressure support ventilation (PSV) or SIMV
• Monitor for excessive respiratory effort and patient self-inflicted lung injury (P-SILI)
• Ensure driving pressure remains <15 cmH₂O during spontaneous efforts
• This approach has better evidence than APRV 3

The bottom line: Stick with guideline-concordant, evidence-based ventilation strategies that have demonstrated mortality benefit rather than experimental modes lacking high-quality supportive evidence 1, 2, 3.